Related Experiment Videos
Neuromuscular blocking effects of succinylcholine in infants and children
Insights
Infants exhibit less profound neuromuscular blockade from succinylcholine compared to children. Recovery rates differ significantly, but surface area dosing reveals linear relationships for blockade intensity and recovery times in both groups.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
Background:
- Succinylcholine is a common neuromuscular blocking agent used in pediatric anesthesia.
- Understanding dose-response relationships and recovery profiles in infants versus children is crucial for safe and effective use.
Purpose of the Study:
- To compare the neuromuscular blocking effects and recovery times of succinylcholine in infants and children.
- To investigate the relationship between succinylcholine dosage (weight and surface area based) and neuromuscular blockade parameters.
Main Methods:
- 16 infants and 16 children received two doses of succinylcholine on a weight basis (0.5 and 1.0 mg/kg).
- Neuromuscular blockade intensity and recovery times (to 10%, 50%, and 90% transmission) were measured.
- Dose-response relationships were analyzed using weight-based and surface area-based calculations.
Main Results:
- Infants showed less profound blockade than children at both 0.5 and 1.0 mg/kg.
- Equipotent doses (1 mg/kg in infants vs. 0.5 mg/kg in children) resulted in similar recovery times to 10% and 90% transmission.
- Recovery from 50% to 90% transmission was significantly slower in infants (46.4%/min) than in children (69.1%/min).
- Surface area dosing demonstrated linear relationships between log dose and recovery times (50% and 90%) and maximum blockade intensity.
Conclusions:
- Infants require higher succinylcholine doses on a weight basis for comparable blockade intensity to children.
- Recovery rates from neuromuscular blockade vary between infants and children, with infants recovering more slowly.
- Surface area dosing provides a more consistent model for predicting succinylcholine's neuromuscular effects across pediatric age groups.
Abstract:
The neuromuscular blocking effects and recovery times following two doses of succinylcholine on a weight basis were evaluated in 16 infants and 16 children. Infants had less profound neuromuscular blockade than children at both 0.5 and 1.0 mg/kg doses. Succinylcholine, 1 mg/kg, in infants produced blockade equal to that produced by 0.5 mg/kg in children; at these equipotent doses there was no statistically significant difference between the times to recover to 10 and 90 per cent neuromuscular transmission in the two groups. However, the rate of recovery from 50 per cent neuromuscular transmission to 90 per cent neuromuscular transmission was 69.1 per cent/min in children, as opposed to 46.4 per cent/min in infants. When dosage was calculated on a surface area basis, there was a linear relationship for infants and children as a single group between the log dose and the times to recover to 50 and 90 per cent neuromuscular transmission. Similarly, there was a linear relationship between the log dose (mg/m2) and the maximum intensity of neuromuscular blockade.